DRUG DISCOVERY FROM TECHNOLOGY NETWORKS

Monoclonal antibodies (mAbs) have been used as therapeutic agents over the past several decades. Their specificity and ability to trigger the...

The following article is an opinion piece written by Kevin Seaver. The views and opinions expressed in this article are those of the author and...

Trends in today’s population provide pharmaceutical companies with a dual-pronged challenge. On one side of the spectrum the population is...

The biotechnology company Angany recently announced the successful production of neutralizing monoclonal antibodies (NAbs) derived from the...

At present, the COVID-19 pandemic is still ongoing in many parts of the world, causing severe socio-economic problems. Therefore, rapid...